Search

Your search keyword '"Kurt Kletter"' showing total 195 results

Search Constraints

Start Over You searched for: Author "Kurt Kletter" Remove constraint Author: "Kurt Kletter"
195 results on '"Kurt Kletter"'

Search Results

1. Imaging of Primitive Neuroectodermal Tumor (PNET) by Technetium-99m Tetrofosmin

2. Supplementary Table 2 from Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients

Catalog

Books, media, physical & digital resources

3. Supplementary Table 1 from Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

4. Supplementary Figure 1 from Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

5. Data from Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

6. Supplementary Figure 2 from Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

7. Supplementary Table 2 from Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

8. Supplementary Figure Legends from Evaluation of Diffusion-Weighted MRI for Pretherapeutic Assessment and Staging of Lymphoma: Results of a Prospective Study in 140 Patients

9. Supplementary Table 1 from Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients

12. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT–Controlled Prospective Study in 64 Patients

13. Can Interim 18F-FDG PET or Diffusion-Weighted MRI Predict End-of-Treatment Outcome in FDG-Avid MALT Lymphoma After Rituximab-Based Therapy?: A Preliminary Study in 15 Patients

14. PET based volume segmentation with emphasis on the iterative TrueX algorithm

15. Microfluidic preparation of [18F]FE@SUPPY and [18F]FE@SUPPY:2 — comparison with conventional radiosyntheses

16. The stability of methyl-, ethyl- and fluoroethylesters against carboxylesterases in vitro: there is no difference

17. Evaluating repetitive18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer

18. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions

19. Hypothalamic serotonin-1A receptor binding measured by PET predicts the plasma level of dehydroepiandrosterone sulfate in healthy women

20. 'Label and go' – A fast and easy radiolabelling method for pellets

21. Diagnostic imaging in Merkel cell carcinoma: Lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET

22. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects

23. Age dependency of cerebral P-gp function measured with (R)-[11C]verapamil and PET

24. Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume

25. The serotonin-1A receptor distribution in healthy men and women measured by PET and [carbonyl-11C]WAY-100635

26. Multimodal imaging of human early visual cortex by combining functional and molecular measurements with fMRI and PET

27. No Immunological Benefit of Selenium in Consecutive Patients with Autoimmune Thyroiditis

28. Preparation and first evaluation of [18F]FE@SUPPY: a new PET tracer for the adenosine A3 receptor

29. Radiologie in einem prägraduellen problembasiert-integrierten Medizincurriculum

30. Simple and fully automated preparation of [carbonyl-11C]WAY-100635

31. Pharmacoresistance in Epilepsy: A Pilot PET Study with the P-Glycoprotein Substrate R -[11 C]verapamil

32. Preparation and radiosynthesis of [18F]FE@CFN (2-[18F]fluoroethyl 4-[N-(1-oxopropyl)-N-phenylamino]-1-(2-phenylethyl)-4-piperidinecarboxylate): a potential μ-opioid receptor imaging agent

33. Comparison of11C-acetate positron emission tomography and67Gallium citrate scintigraphy in patients with hepatocellular carcinoma

34. [18F]FETO: metabolic considerations

35. [18F]FETO for adrenocortical PET imaging: a pilot study in healthy volunteers

36. NCA nucleophilic radiofluorination on substituted benzaldehydes for the preparation of [18F]fluorinated aromatic amino acids

37. Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts

38. FDG gamma camera PET equipped with one inch crystal and XCT

39. Synthesis of fluorine-18-labelled 5- and 6-fluoro-2-pyridinamine

40. Colonic spread and serum pharmacokinetics of budesonide foam in patients with mildly to moderately active ulcerative colitis

41. Influence of functional haplotypes in the drug transporter gene on central nervous system drug distribution in humans

42. FDG PET is superior to CT in the prediction of viable tumour in post-chemotherapy seminoma residuals

43. Synthesis of 1,1′ [11C]-methylene-di-(2-naphthol) ([11C]ST1859) for PET studies in humans

44. [ 18 F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans

45. In vitro and in vivo evaluation of [18F]ciprofloxacin for the imaging of bacterial infections with PET

46. Radiosynthesis and in vitro evaluation of the 5HT2 receptor ligand [N-11C-methyl]-1-[2,5-dimethoxy-4-iodophenyl]-2-methylaminopropane for PET

47. Biological evaluation of 2′-[18F]fluoroflumazenil ([18F]FFMZ), a potential GABA receptor ligand for PET

48. Synthesis and biodistribution of [18F]FE@CIT, a new potential tracer for the dopamine transporter

49. Radiosynthesis of 3-(2′-[18F]fluoro)-flumazenil ([18F]FFMZ)

50. Comparison of three different purification methods for the routine preparation of [11C] Metomidate